Manning Paul B

Director | Director, 10% Owner | 10% Owner

5 companies

Average

Trades Analyzed

12M Win Rate

43.5%

Avg 3M Return

-5.5%

Avg 12M Return

-13.5%

Manning Paul B is a 10% Owner at ABOS with holdings across 5 companies. Recent SEC Form 4 filings include 12 buys and 4 sells.

Estimated insider holdings value: $92.7M based on current market prices.

Holdings by Company

ABOSJul 6, 2021

Current Shares3.35M

Value$8.53M

Net Activity+312.5K

Bought: 312.5KSold: 0

VRCANov 25, 2025

Current Shares3.35M

Value$26.35M

Net Activity+33.47M

Bought: 33.47MSold: 0

TSHAMay 30, 2025

Current Shares2.84M

Value$19.52M

Net Activity+20.39M

Bought: 20.39MSold: 0

CADLJun 25, 2025

Current Shares2.21M

Value$18.16M

Net Activity+1.31M

Bought: 1.31MSold: 0

LQDAFeb 11, 2026

Current Shares469.6K

Value$20.10M

Net Activity+536.1K

Bought: 1.21MSold: 670.8K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 25, 2025	VRCA Verrica Pharmaceuticals Inc.	Director, 10% Owner	Buy	4,126,142	$4.24	$17,505,157.44	+129.7%	+9.4%	-
Sep 2, 2025	LQDA Liquidia Corp	Director	Sell	670,837	$28.26	$18,957,475.28	-20.2%	+12.1%	-
May 30, 2025	TSHA Taysha Gene Therapies, Inc.	10% Owner	Buy	750,000	$2.75	$2,062,500.00	+35.9%	+4.4%	-
Dec 16, 2024	CADL Candel Therapeutics, Inc.	Director	Buy	1,250,000	$6.00	$7,500,000.00	+104.5%	+43.5%	-6.7%
Nov 22, 2024	VRCA Verrica Pharmaceuticals Inc.	Director, 10% Owner	Buy	22,921,348	$0.00	-	+245.6%	-25.4%	-57.7%
Sep 12, 2024	LQDA Liquidia Corp	Director	Buy	337,078	$8.90	$2,999,994.20	+70.3%	+12.6%	+167.4%
Jun 27, 2024	TSHA Taysha Gene Therapies, Inc.	10% Owner	Buy	1,333,333	$2.25	$2,999,999.25	New	-7.2%	+9.9%
Dec 14, 2023	LQDA Liquidia Corp	Director	Buy	279,330	$7.16	$2,000,002.80	New	+102.1%	+49.8%
Nov 17, 2023	TSHA Taysha Gene Therapies, Inc.	10% Owner	Buy	100,000	$1.63	$163,000.00	+0.6%	-6.5%	+21.2%
Aug 16, 2023	TSHA Taysha Gene Therapies, Inc.	10% Owner	Buy	16,466,667	$0.90	$14,820,000.30	New	-31.1%	+18.7%